Home    Help    Cart    Login
Get Free Updates on Industry Research and Analysis!


Search all reports:
 Go 


Pharma and Biotech News


Marketing Services
Interested in marketing your information product through us? Email us at helpdesk AT pharma-reports.com

or call 800-304-0345




Topic Suggestion?


 Item Detail
Item Detail
You're Here: Medical » Diseases/Disorders



Cancer Vaccines - Trends and Opportunities

Select Your Format:
Price: $2,000.00
Shipping: US:  $0.00 
Non-US  $0.00
QTY:
Print Order form to pay by check
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
Global Data

An essential source of information and analysis on the global cancer vaccines market. The report identifies the key trends shaping and driving the global cancer vaccines market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cancer vaccines sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by our team of industry experts.


Scope

The scope of the report includes:

- Annualized global cancer vaccines market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.

- Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.

- Analysis of the current and future market competition in the global cancer vaccines market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with cancer vaccines.


Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global cancer vaccines market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global cancer vaccines market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What’s the next big thing in the global cancer vaccines market landscape? – Identify, understand and capitalize.


Table of Contents



51 pages

Publication Date : January 2010
 Options
Options
Select Your Format:
 Your Price
Your Price
Price: $2,000.00
Shipping: US:  $0.00 Non-US  $0.00
 QTY: 

Print Order form to pay by check


 Related Items
Related Items
Antihormonal Cancer Therapies: Commercial Insight  Antihormonal Cancer Therapies: Commercial Insight

Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers.  (MORE)
Therapeutic Cancer Vaccines - Prospect of First Approval Set to Reinvigorate Interest from Major Companies - A Pipeline Insight Therapeutic Cancer Vaccines - Prospect of First Approval Set to Reinvigorate Interest from Major Companies - A Pipeline Insight

No therapeutic cancer vaccine has received approval in any of the seven major pharmaceutical markets, despite extensive research efforts. However, with one product in pre-registration in the US, the prospect of the first marketed therapeutic cancer vaccine in the seven major markets is now closer to reality. Scope - Forecast sales of the therapeutic cancer vaccines in late-phase development in the seven major markets over the period 2009 to 2018 - In-depth profiles and analysis for all vaccines in late-phase development, including trial data, SWOT analysis and clinical and commercial potential - Segmentation and analysis of the therapeutic cancer vaccine pipeline by developmental phase, class, indication and technology platform - Insight and analysis of market potential for therapeutic cancer vaccines including commercial opportunity, unmet needs and patient potential Highlights The theoretical market potential for therapeutic cancer vaccines in the seven major markets totals over $4.7 billion.  (MORE)
 

Return policy: We do accept hard copy books if a reason is included. Electronic products including
CD-ROMs and PDF files are non-returnable/non-refundable due to the duplicable nature of these products.

To market your reports, contact us at 800-304-0345 or email
Helpdesk AT PharmaReports DOT com